Laobaixing Pharmacy (603883) - Total Liabilities

Latest as of March 2026: CN¥12.61 Billion CNY ≈ $1.85 Billion USD

Based on the latest financial reports, Laobaixing Pharmacy (603883) has total liabilities worth CN¥12.61 Billion CNY (≈ $1.85 Billion USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Laobaixing Pharmacy - Total Liabilities Trend (2011–2025)

This chart illustrates how Laobaixing Pharmacy's total liabilities have evolved over time, based on quarterly financial data. See Laobaixing Pharmacy (603883) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Laobaixing Pharmacy Competitors by Total Liabilities

The table below lists competitors of Laobaixing Pharmacy ranked by their total liabilities.

Company	Country	Total Liabilities
Regis Healthcare Ltd AU:REG	Australia	AU$2.12 Billion
Centuria Capital Group AU:CNI	Australia	AU$2.16 Billion
Labrador Iron Ore Royalty Corp TO:LIF	Canada	CA$167.46 Million
Sk Gas KO:018670	Korea	₩4.69 Trillion
Anhui Estone Materials Technology Co Ltd SHG:688733	China	CN¥1.29 Billion
OC OERL.CORP ADR 2 SF 1 F:OBH0	Germany	€2.83 Billion
Shanghai SMI Holding Co Ltd SHG:600649	China	CN¥58.62 Billion
Dampskibsselskabet Norden AS CO:DNORD	Denmark	Dkr1.20 Billion

Liability Composition Analysis (2011–2025)

This chart breaks down Laobaixing Pharmacy's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Laobaixing Pharmacy market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.90	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.85	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.63	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Laobaixing Pharmacy's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Laobaixing Pharmacy (2011–2025)

The table below shows the annual total liabilities of Laobaixing Pharmacy from 2011 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥12.85 Billion ≈ $1.88 Billion	-14.27%
2024-12-31	CN¥14.99 Billion ≈ $2.19 Billion	+7.51%
2023-12-31	CN¥13.94 Billion ≈ $2.04 Billion	-2.50%
2022-12-31	CN¥14.30 Billion ≈ $2.09 Billion	+17.41%
2021-12-31	CN¥12.18 Billion ≈ $1.78 Billion	+87.99%
2020-12-31	CN¥6.48 Billion ≈ $948.04 Million	+7.09%
2019-12-31	CN¥6.05 Billion ≈ $885.24 Million	+18.26%
2018-12-31	CN¥5.12 Billion ≈ $748.55 Million	+42.18%
2017-12-31	CN¥3.60 Billion ≈ $526.47 Million	+21.37%
2016-12-31	CN¥2.96 Billion ≈ $433.78 Million	+96.50%
2015-12-31	CN¥1.51 Billion ≈ $220.75 Million	+4.47%
2014-12-31	CN¥1.44 Billion ≈ $211.31 Million	+14.31%
2013-12-31	CN¥1.26 Billion ≈ $184.85 Million	+43.11%
2012-12-31	CN¥882.72 Million ≈ $129.17 Million	-3.30%
2011-12-31	CN¥912.83 Million ≈ $133.58 Million	--

About Laobaixing Pharmacy

SHG:603883 China Pharmaceutical Retailers

Market Cap

$1.31 Billion

CN¥8.97 Billion CNY

Market Cap Rank

#7904 Global

#1887 in China

Share Price

CN¥11.82

Change (1 day)

-0.17%

52-Week Range

CN¥11.62 - CN¥21.50

All Time High

CN¥331.82